These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26955523)

  • 41. Granulomatous tenosynovitis and carpal tunnel syndrome caused by Sporothrix schenckii.
    Stratton CW; Lichtenstein KA; Lowenstein SR; Phelps DB; Reller LB
    Am J Med; 1981 Jul; 71(1):161-4. PubMed ID: 7246574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular identification of the Sporothrix schenckii complex.
    Oliveira MM; Almeida-Paes R; Gutierrez-Galhardo MC; Zancope-Oliveira RM
    Rev Iberoam Micol; 2014; 31(1):2-6. PubMed ID: 24270070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Feline sporotrichosis: epidemiological and clinical aspects.
    Gremião ID; Menezes RC; Schubach TM; Figueiredo AB; Cavalcanti MC; Pereira SA
    Med Mycol; 2015 Jan; 53(1):15-21. PubMed ID: 25477076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antifungal susceptibilities and identification of species of the Sporothrix schenckii complex isolated in Brazil.
    Ottonelli Stopiglia CD; Magagnin CM; Castrillón MR; Mendes SD; Heidrich D; Valente P; Scroferneker ML
    Med Mycol; 2014 Jan; 52(1):56-64. PubMed ID: 23964828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endemic of zoonotic sporotrichosis: profile of cases in children.
    Barros MB; Costa DL; Schubach TM; do Valle AC; Lorenzi NP; Teixeira JL; Schubach Ade O
    Pediatr Infect Dis J; 2008 Mar; 27(3):246-50. PubMed ID: 18277928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic vaccine using a monoclonal antibody against a 70-kDa glycoprotein in mice infected with highly virulent Sporothrix schenckii and Sporothrix brasiliensis.
    de Almeida JR; Kaihami GH; Jannuzzi GP; de Almeida SR
    Med Mycol; 2015 Jan; 53(1):42-50. PubMed ID: 25533623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A cell wall protein-based vaccine candidate induce protective immune response against Sporothrix schenckii infection.
    Portuondo DL; Batista-Duharte A; Ferreira LS; Martínez DT; Polesi MC; Duarte RA; de Paula E Silva AC; Marcos CM; Almeida AM; Carlos IZ
    Immunobiology; 2016 Feb; 221(2):300-9. PubMed ID: 26547105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The NLRP3 inflammasome contributes to host protection during Sporothrix schenckii infection.
    Gonçalves AC; Ferreira LS; Manente FA; de Faria CMQG; Polesi MC; de Andrade CR; Zamboni DS; Carlos IZ
    Immunology; 2017 Jun; 151(2):154-166. PubMed ID: 28140444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emergence of pathogenicity in the Sporothrix schenckii complex.
    Rodrigues AM; de Hoog S; de Camargo ZP
    Med Mycol; 2013 May; 51(4):405-12. PubMed ID: 22989196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Perinaud's oculoglandular syndrome as a manifestation of cat-scratch disease].
    Kruse LP; Engbaek K
    Ugeskr Laeger; 1995 Jul; 157(29):4137-8. PubMed ID: 7544512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Susceptibility of species within the Sporothrix schenckii complex to a panel of killer yeasts.
    Stopiglia CD; Heidrich D; Sorrentino JM; Vieira FJ; Landell MF; Valente P; Scroferneker ML
    J Basic Microbiol; 2014 Jun; 54(6):578-84. PubMed ID: 23686831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation of Sporothrix schenckii from the environmental sources of cutaneous sporotrichosis patients in Himachal Pradesh, India: results of a pilot study.
    Mehta KI; Sharma NL; Kanga AK; Mahajan VK; Ranjan N
    Mycoses; 2007 Nov; 50(6):496-501. PubMed ID: 17944713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sporothrix schenckii associated with armadillo hunting in Southern Brazil: epidemiological and antifungal susceptibility profiles.
    Alves SH; Boettcher CS; Oliveira DC; Tronco-Alves GR; Sgaria MA; Thadeu P; Oliveira LT; Santurio JM
    Rev Soc Bras Med Trop; 2010; 43(5):523-5. PubMed ID: 21085862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sporothrix schenckii var luriei as the cause of sporotrichosis in Italy.
    Alberici F; Paties CT; Lombardi G; Ajello L; Kaufman L; Chandler F
    Eur J Epidemiol; 1989 Jun; 5(2):173-7. PubMed ID: 2670603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parinaud's oculoglandular syndrome; report of a case of obscure etiology.
    MICHELS MW
    Perm Found Med Bull; 1947 Mar; 5(1):46-8. PubMed ID: 20291657
    [No Abstract]   [Full Text] [Related]  

  • 56. Parinaud «plus» syndrome in a patient with dysgerminoma.
    Burgueño-Montañés C; Santalla-Castro C; Peña-Suárez J
    Arch Soc Esp Oftalmol; 2016 Jul; 91(7):341-5. PubMed ID: 26900044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bartonella henselae associated with Parinaud's oculoglandular syndrome.
    Grando D; Sullivan LJ; Flexman JP; Watson MW; Andrew JH
    Clin Infect Dis; 1999 May; 28(5):1156-8. PubMed ID: 10452652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The epidemiological scenario of feline sporotrichosis in Rio de Janeiro, State of Rio de Janeiro, Brazil.
    Pereira SA; Gremião ID; Kitada AA; Boechat JS; Viana PG; Schubach TM
    Rev Soc Bras Med Trop; 2014; 47(3):392-3. PubMed ID: 25075494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of cutaneous sporotrichosis with itraconazole--study of 645 patients.
    de Lima Barros MB; Schubach AO; de Vasconcellos Carvalhaes de Oliveira R; Martins EB; Teixeira JL; Wanke B
    Clin Infect Dis; 2011 Jun; 52(12):e200-6. PubMed ID: 21628477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole.
    Borba-Santos LP; Gagini T; Ishida K; de Souza W; Rozental S
    J Med Microbiol; 2015 Apr; 64(Pt 4):415-422. PubMed ID: 25681323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.